Is DHT more potent than testosterone because it binds the androgen receptor more strongly and forms a more stable complex?

Dihydrotestosterone (DHT) is a metabolite of testosterone that serves as the primary mediator of androgenic action in many tissues. Its biological role is defined by its ability to amplify the signals initially provided by testosterone, particularly in the prostate, skin, and hair follicles.

Mechanisms of enhanced potency

Research consistently demonstrates that DHT is a significantly more potent androgen than testosterone due to its superior binding characteristics with the androgen receptor (AR). While both hormones act as agonists, DHT’s structural configuration allows for a more efficient and robust activation of the receptor.

• Binding affinity: DHT exhibits a lower equilibrium dissociation constant ($K_d$)—approximately 0.22 nM—compared to the higher $K_d$ of testosterone, indicating a much stronger attraction to the receptor.
• Kinetic stability: A primary driver of DHT's potency is its markedly slower dissociation rate ($k_{off}$) from the receptor. DHT remains bound to the AR for a longer duration (longer residence time) than testosterone, leading to prolonged receptor occupancy and more sustained transcriptional activity.
• Amplification: In specific tissues, the enzyme 5$\alpha$-reductase converts testosterone into DHT. This conversion increases androgenic potency by approximately 2 to 10 times, effectively "charging" the androgenic signal within target cells.

Structural and molecular stability

The superior stability of the DHT-AR complex is rooted in the precise molecular fit of the hormone within the ligand-binding domain (LBD) of the receptor.

• Optimized molecular fit: DHT’s 5$\alpha$-reduced A-ring structure allows it to fit more securely within the AR-LBD pocket. High-resolution crystal structures show that this configuration enables more stable hydrogen bonding with key amino acid residues, such as Asn705 and Thr877.
• Conformational rigidity: Molecular dynamics simulations indicate that DHT binding reduces the mobility of the receptor’s structural elements more effectively than testosterone. This rigidity helps stabilize the "activation function 2" (AF2) surface, which is essential for recruiting the co-activator proteins required for gene expression.
• Thermodynamic stability: DHT-AR complexes possess greater binding energy and stability than testosterone-AR complexes. Research shows that DHT increases the Gibbs free energy of unfolding significantly more than testosterone, confirming a more physically robust receptor-ligand complex.

Bottom line

DHT is more potent than testosterone because it binds the androgen receptor with higher affinity and forms a more stable complex characterized by a slower dissociation rate. These molecular advantages allow DHT to more effectively trigger the genetic signaling required for androgenic physiological effects.